PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Invesco Dynamic Biotechnology & Genome ETF (PBE)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

ETF Info

ISIN

US73935X8561

CUSIP

46137V787

Issuer

Invesco

Inception Date

Jun 23, 2005

Region

North America (U.S.)

Leveraged

1x

Index Tracked

Dynamic Biotech & Genome Intellidex Index (AMEX)

Asset Class

Equity

Asset Class Size

Multi-Cap

Asset Class Style

Growth

Expense Ratio

PBE features an expense ratio of 0.59%, falling within the medium range.


Expense ratio chart for PBE: current value at 0.59% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.59%

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
PBE vs. PJP PBE vs. ARKG PBE vs. IBB PBE vs. IBBQ PBE vs. IDNA PBE vs. BBH PBE vs. FBT PBE vs. QQQ PBE vs. XBI PBE vs. IYH
Popular comparisons:
PBE vs. PJP PBE vs. ARKG PBE vs. IBB PBE vs. IBBQ PBE vs. IDNA PBE vs. BBH PBE vs. FBT PBE vs. QQQ PBE vs. XBI PBE vs. IYH

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Invesco Dynamic Biotechnology & Genome ETF, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


340.00%360.00%380.00%400.00%JulyAugustSeptemberOctoberNovemberDecember
371.63%
393.94%
PBE (Invesco Dynamic Biotechnology & Genome ETF)
Benchmark (^GSPC)

Returns By Period

Invesco Dynamic Biotechnology & Genome ETF had a return of 2.15% year-to-date (YTD) and 3.91% in the last 12 months. Over the past 10 years, Invesco Dynamic Biotechnology & Genome ETF had an annualized return of 3.42%, while the S&P 500 had an annualized return of 11.06%, indicating that Invesco Dynamic Biotechnology & Genome ETF did not perform as well as the benchmark.


PBE

YTD

2.15%

1M

-0.62%

6M

3.23%

1Y

3.91%

5Y*

3.57%

10Y*

3.42%

^GSPC (Benchmark)

YTD

24.34%

1M

0.23%

6M

8.53%

1Y

24.95%

5Y*

13.01%

10Y*

11.06%

Monthly Returns

The table below presents the monthly returns of PBE, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-2.32%1.95%-1.25%-5.94%3.98%2.41%8.27%2.42%-2.85%-2.32%3.37%2.15%
20235.17%-4.73%-1.34%-0.28%-3.67%1.66%3.53%-2.98%-7.35%-6.04%9.34%12.36%3.71%
2022-14.72%-0.76%2.92%-9.33%1.26%1.39%5.68%-0.89%-2.55%7.62%5.03%-4.69%-10.83%
20217.92%-2.00%-0.47%2.17%-2.92%5.61%-2.50%4.10%-4.65%0.31%-6.10%1.03%1.54%
2020-3.25%-7.27%-7.14%14.54%8.99%0.39%1.26%-0.56%-3.50%-0.14%12.99%9.77%25.66%
201911.64%4.32%0.67%-5.43%-7.25%10.56%-1.10%-5.54%-5.25%7.72%8.44%0.92%18.65%
201810.54%-1.84%-3.81%-2.32%7.03%6.32%5.03%4.47%-0.96%-13.80%3.42%-11.19%-0.19%
20175.00%7.07%-2.95%1.92%-2.99%9.78%1.97%4.70%2.40%-6.63%-0.99%2.17%22.28%
2016-23.73%-4.33%3.85%2.72%3.51%-9.12%11.38%-2.52%4.53%-10.92%9.02%-4.46%-22.90%
20155.52%3.49%0.58%-3.97%9.17%1.15%1.93%-9.93%-14.45%9.40%1.94%-0.30%1.72%
201413.25%7.60%-7.80%-4.66%-0.76%11.56%-1.65%11.14%-3.18%7.94%1.74%-1.10%36.34%
20138.60%-0.32%6.07%7.93%5.41%-3.16%13.15%0.70%6.53%0.29%8.05%-2.50%62.24%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of PBE is 22, meaning it’s performing worse than 78% of other ETFs on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of PBE is 2222
Overall Rank
The Sharpe Ratio Rank of PBE is 2121
Sharpe Ratio Rank
The Sortino Ratio Rank of PBE is 2222
Sortino Ratio Rank
The Omega Ratio Rank of PBE is 2121
Omega Ratio Rank
The Calmar Ratio Rank of PBE is 2020
Calmar Ratio Rank
The Martin Ratio Rank of PBE is 2424
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Invesco Dynamic Biotechnology & Genome ETF (PBE) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for PBE, currently valued at 0.31, compared to the broader market0.002.004.000.312.10
The chart of Sortino ratio for PBE, currently valued at 0.56, compared to the broader market-2.000.002.004.006.008.0010.000.562.80
The chart of Omega ratio for PBE, currently valued at 1.07, compared to the broader market0.501.001.502.002.503.001.071.39
The chart of Calmar ratio for PBE, currently valued at 0.20, compared to the broader market0.005.0010.0015.000.203.09
The chart of Martin ratio for PBE, currently valued at 1.34, compared to the broader market0.0020.0040.0060.0080.00100.001.3413.49
PBE
^GSPC

The current Invesco Dynamic Biotechnology & Genome ETF Sharpe ratio is 0.31. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Invesco Dynamic Biotechnology & Genome ETF with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.503.003.50JulyAugustSeptemberOctoberNovemberDecember
0.31
2.10
PBE (Invesco Dynamic Biotechnology & Genome ETF)
Benchmark (^GSPC)

Dividends

Dividend History

Invesco Dynamic Biotechnology & Genome ETF provided a 0.05% dividend yield over the last twelve months, with an annual payout of $0.03 per share.


0.00%0.20%0.40%0.60%0.80%1.00%1.20%$0.00$0.10$0.20$0.30$0.40$0.50$0.602014201520162017201820192020202120222023
Dividends
Dividend Yield
PeriodTTM2023202220212020201920182017201620152014
Dividend$0.03$0.01$0.00$0.00$0.03$0.00$0.00$0.27$0.15$0.57$0.28

Dividend yield

0.05%0.02%0.00%0.00%0.04%0.00%0.00%0.57%0.38%1.12%0.55%

Monthly Dividends

The table displays the monthly dividend distributions for Invesco Dynamic Biotechnology & Genome ETF. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024$0.00$0.00$0.02$0.00$0.00$0.01$0.00$0.00$0.00$0.00$0.00$0.00$0.03
2023$0.00$0.00$0.00$0.00$0.00$0.01$0.00$0.00$0.00$0.00$0.00$0.00$0.01
2022$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2021$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2020$0.00$0.00$0.03$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.03
2019$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2018$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2017$0.00$0.00$0.06$0.00$0.00$0.22$0.00$0.00$0.00$0.00$0.00$0.00$0.27
2016$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.03$0.00$0.00$0.12$0.15
2015$0.00$0.00$0.00$0.00$0.00$0.12$0.00$0.00$0.14$0.00$0.00$0.31$0.57
2014$0.23$0.00$0.00$0.04$0.00$0.00$0.00$0.28

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-20.00%-15.00%-10.00%-5.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-19.74%
-2.62%
PBE (Invesco Dynamic Biotechnology & Genome ETF)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Invesco Dynamic Biotechnology & Genome ETF. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Invesco Dynamic Biotechnology & Genome ETF was 45.69%, occurring on Mar 9, 2009. Recovery took 407 trading sessions.

The current Invesco Dynamic Biotechnology & Genome ETF drawdown is 19.74%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-45.69%Oct 16, 2007351Mar 9, 2009407Oct 18, 2010758
-44.56%Jul 20, 2015238Jun 27, 20161022Jul 20, 20201260
-37.84%Feb 9, 2021340Jun 14, 2022
-26.36%May 13, 201160Aug 8, 2011227Jul 2, 2012287
-21.12%Feb 28, 200697Jul 17, 2006192Apr 23, 2007289

Volatility

Volatility Chart

The current Invesco Dynamic Biotechnology & Genome ETF volatility is 5.85%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%7.00%8.00%JulyAugustSeptemberOctoberNovemberDecember
5.85%
3.79%
PBE (Invesco Dynamic Biotechnology & Genome ETF)
Benchmark (^GSPC)
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab